Kaplan–Meier analysis using PrognoScan indicated decreased survival in patients with low HOXD10 expression, therefore confirming the IHC results presented by Li et al. It has been shown that HOXD10 suppresses the invasive capacity of GBM via uPAR, MMP14, and RhoC inhibition [190]. Here, HOXD10 is linked to glioblastoma.